The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk

Journal: Science Translational Medicine

Published: 2019-08-14

DOI: 10.1126/scitranslmed.aau2291

Affiliations: 27

Authors: 36

Go to article
Institutions Share
Department of Psychiatry, WUSTL, United States of America (USA) 0.30
Department of Neurology, WUSTL, United States of America (USA) 0.12
Hope Center for Neurological Disorders, WUSTL, United States of America (USA) 0.06
Department of Internal Medicine and Clinical Nutrition, GU, Sweden 0.04
Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Spain 0.04
Institute of Biomedical Research (IIB Sant Pau), Spain 0.04
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain 0.04
Washington University School of Medicine (WUSM), WUSTL, United States of America (USA) 0.04
Sahlgrenska University Hospital (SU), GU, Sweden 0.03
Department of Clinical Sciences - Lund, LU, Sweden 0.03
Institute for Stroke and Dementia Research (ISD), LMU, Germany 0.03
Cluster of Excellence - Munich Cluster for Systems Neurology (SyNergy), LMU, Germany 0.03
Biomedical Center München (BMC), LMU, Germany 0.02
Department of Biochemistry (BC), LMU, Germany 0.02
UCL Department of Neurodegenerative Disease, United Kingdom (UK) 0.02
Barcelonabeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Spain 0.02
German Center for Neurodegenerative Diseases within the Helmholtz Association (DZNE), Germany 0.02
Department of Psychiatry and Neurochemistry, GU, Sweden 0.02
Institute of Neuroscience and Physiology, GU, Sweden 0.02
Division of Pulmonary and Critical Care Medicine, WUSTL, United States of America (USA) 0.01
UK DRI at UCL (UK DRI UCL), United Kingdom (UK) 0.01
Wisconsin Alzheimer's Disease Research Center (ADRC), UW-Madison, United States of America (USA) 0.01
Chair of Metabolic Biochemistry, LMU, Germany 0.01
Brain and Mind Centre, USYD, Australia 0.01
ISAR Bioscience GmbH, Germany 0.01